Beate E. Preuss - Publications

Humoral responses to SARS-CoV-2 vaccination in allogeneic hematopoietic cell transplantation patients resemble that of healthy individuals.

Journal: Frontiers in immunology

Published: March 12, 2026

SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy.

Journal: Frontiers in immunology

Published: October 14, 2024

IgA-autoantibodies to histone 2B allow to differentiate between alcohol- and metabolic dysfunction-associated steatotic liver disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 09, 2024

Response to letter to the editor: tubulin beta is not the target of antineutrophil antibodies in primary sclerosing cholangitis.

Journal: Clinical and experimental immunology

Published: July 10, 2024

Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.

Journal: Clinical and experimental immunology

Published: June 26, 2023

Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium.

Journal: Autoimmunity reviews

Published: February 09, 2023

Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome.

Journal: Rheumatology (Oxford, England)

Published: May 02, 2022

Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Journal: Journal of clinical medicine

Published: December 05, 2021

Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.

Journal: Frontiers in immunology

Published: September 29, 2021

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.

Journal: Vaccines

Published: March 23, 2021

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.

Journal: Nature immunology

Published: June 10, 2020

Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes.

Journal: Frontiers in immunology

Published: March 06, 2020